Skip to content
  • About us
    • Advisory Board
    • Our Mission
    • Privacy policy
    • GDPR Policy
  • Editorial Guidelines
    • Peer-review protocol
    • Author guidelines
    • Editorial Calendar 2018
  • ADVERTISE WITH US
    • Media Information 2019
    • Media Information 2018
    • Mechanical specifications
    • Newsletter
    • Web banner specifications
  • Subscribe
    • Weekly newsletter
  • Contact Us
Top Menu
IPI International Pharmaceutical Industry
Peer Reviewed, Contemporary, Authoritative
IPI International Pharmaceutical IndustryIPI International Pharmaceutical Industry

  • Home Page
  • Current Features/ Volume 10 Issue 4
  • Editorial Archive
    • Volume 10 Issue 3
    • Volume 10 Issue 2
    • Volume 10 Issue 1
    • Volume 9 Issue 4
    • Volume 9 Issue 3
    • Volume 9 Issue 2
    • Volume 8 Issue 1
    • Volume 7 Issue 4
    • Volume 7 Issue 3
    • Volume 7 Issue 2
    • Volume 7 Issue 1
    • Volume 6 Issue 4
    • Volume 6 Issue 3
    • Volume 6 Issue 2
    • Volume 6 Issue 1
    • Volume 5 Issue 4
    • Volume 5 Issue 3
    • Volume 5 Issue 2
    • Volume 5 Issue 1
    • Volume 4 Issue 4
    • Volume 4 Issue 3
    • Volume 4 Issue 2
    • Volume 4 Issue 1
    • Volume 3 Issue 4
    • Volume 3 Issue 3
    • Volume 3 Issue 2
  • Archived Issues
  • Events
  • Company profile
    • A-D
    • E-M
    • N-S
    • T-Z
  • Sponsored Articles
  • News
    • Clinical Trials Advisor
    • Drug Industry Daily
    • Drug GMP Report
    • Manufacturing & Packaging
    • Discovery & Development
  • Home Page
  • Current Features/ Volume 10 Issue 4
  • Editorial Archive
    • Volume 10 Issue 3
    • Volume 10 Issue 2
    • Volume 10 Issue 1
    • Volume 9 Issue 4
    • Volume 9 Issue 3
    • Volume 9 Issue 2
    • Volume 8 Issue 1
    • Volume 7 Issue 4
    • Volume 7 Issue 3
    • Volume 7 Issue 2
    • Volume 7 Issue 1
    • Volume 6 Issue 4
    • Volume 6 Issue 3
    • Volume 6 Issue 2
    • Volume 6 Issue 1
    • Volume 5 Issue 4
    • Volume 5 Issue 3
    • Volume 5 Issue 2
    • Volume 5 Issue 1
    • Volume 4 Issue 4
    • Volume 4 Issue 3
    • Volume 4 Issue 2
    • Volume 4 Issue 1
    • Volume 3 Issue 4
    • Volume 3 Issue 3
    • Volume 3 Issue 2
  • Archived Issues
  • Events
  • Company profile
    • A-D
    • E-M
    • N-S
    • T-Z
  • Sponsored Articles
  • News
    • Clinical Trials Advisor
    • Drug Industry Daily
    • Drug GMP Report
    • Manufacturing & Packaging
    • Discovery & Development
Breaking News
  • BIO-Europe Spring® 2019 ...February 18, 2019
  • Recipharm announces all its facilities are ready for EU ...February 14, 2019
  • Q&A for the Althea UK launch ...February 13, 2019
  • Australian medicinal cannabis company Althea to launch ...February 13, 2019
  • Nano drops a million times smaller than a teardrop expl ...February 13, 2019

Category Archives: News

Investments in quality leadership and production optimization: Raumedic gears for Industry 4.0

NewsBy adminipi20th September 2017

Helmbrechts – Raumedic AG is introducing a new IT-based quality-assurance and production-control system as a way of raising its high quality…

Read more

Taconic Biosciences – A fully-licensed, global leader in genetically engineered rodent models and services

NewsBy adminipi18th September 2017

Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology…

Read more

Tetraphase Pharmaceuticals Completes Enrollment of IGNITE3 Phase 3 Clinical Trial of Eravacycline in Complicated Urinary Tract Infections

NewsBy adminipi18th September 2017

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced…

Read more

Sanofi and Regeneron Announce Positive Study Results for Dupixent® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis

NewsBy adminipi18th September 20171 Comment

– Late-breaking oral abstract of Phase 3 CAFÉ study presented at the 26th European Academy of Dermatology and Venereology (EADV) Congress –…

Read more

FDA Approves Mvasi

NewsBy adminipi18th September 2017

FDA Approves Mvasi (bevacizumab-awwb), a Biosimilar to Avastin The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a…

Read more

Bayer gears up to take on Gilead in lymphoma with Aliqopa green light

NewsBy adminipi18th September 2017

Bayer only won its FDA priority review for lymphoma prospect copanlisib this May, but that was long enough for the agency to…

Read more

NxtPort and Air Cargo Belgium / BRUcloud connect air and sea for cargo transport

Drug Industry Daily, NewsBy adminipi14th September 2017

Data platform NxtPort and Air Cargo Belgium (via its data sharing platform BRUcloud) will work together on multimodal solutions. Companies…

Read more

Wickham Labs to Exhibit at Medtec Ireland 2017

Drug Industry Daily, NewsBy adminipi14th September 20172 Comments

Wickham Laboratories Ltd is pleased to announce that we will be on stand 305 at the upcoming Medtec Ireland, held…

Read more

Oxford Genetics Supports Significant Growth with New U.S. Office

NewsBy adminipi12th September 2017

Company to extend its presence into the U.S. as a key cell and gene therapy market  12 September, 2017, Oxford –…

Read more

Recipharm and CTC launch integrated first in human service

NewsBy adminipi12th September 2017

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch…

Read more
1
2345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
…8384858687…
888990919293949596979899100101102103104105106107108109110111112113114
115
Events
© 2019 IPI Media, All Rights Reserved. Powered by Teksyte LTD
  •  
  •  
  •  
  •  
CSC Footer Navigation
Go to Top
This site uses cookies and by using the site you are consenting to this. Find out why we use cookies and how to manage your settings. Full details can be found here. Read More Accept
Privacy & Cookies Policy